WANTAI BIOLOGICAL(SH:603392) Xin Jing Bao·2025-09-11 06:07Group 1 - The core point of the article is that the HPV vaccine has been included in the national immunization program in China, with the domestically developed nine-valent HPV vaccine officially in use [1] - The National Health Commission announced that HPV vaccination services will be provided for eligible girls this year, enhancing the accessibility and affordability of HPV vaccines in China [1] - The nine-valent HPV vaccine developed by Wantai Biological Pharmacy has been approved for market launch, making it the first domestically produced nine-valent HPV vaccine in China and the second globally [1] Group 2 - The price of the domestically produced nine-valent HPV vaccine is set at 499 yuan per dose, which is approximately 40% of the price of imported similar products [2] - For females aged 9 to 17, a two-dose vaccination schedule costs a total of 998 yuan, while for those aged 18 to 45, a three-dose schedule costs about 1500 yuan [2]